Canada markets closed

Moleculin Biotech, Inc. (MBRX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.08+0.01 (+0.20%)
At close: 04:00PM EDT
4.85 -0.23 (-4.53%)
After hours: 04:30PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 11.74M
Enterprise Value -4.52M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.54
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.52

Trading Information

Stock Price History

Beta (5Y Monthly) 1.85
52-Week Change 3719.35%
S&P500 52-Week Change 326.49%
52 Week High 36.24
52 Week Low 30.34
50-Day Moving Average 34.06
200-Day Moving Average 31.43

Share Statistics

Avg Vol (3 month) 398.12k
Avg Vol (10 day) 333.06k
Shares Outstanding 52.31M
Implied Shares Outstanding 62.31M
Float 81.93M
% Held by Insiders 14.65%
% Held by Institutions 115.53%
Shares Short (Apr 30, 2024) 431.1k
Short Ratio (Apr 30, 2024) 41.22
Short % of Float (Apr 30, 2024) 41.39%
Short % of Shares Outstanding (Apr 30, 2024) 41.35%
Shares Short (prior month Mar 28, 2024) 444.95k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 01, 2021
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Mar 22, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-38.73%
Return on Equity (ttm)-76.07%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -29.5M
Net Income Avi to Common (ttm)-29.77M
Diluted EPS (ttm)-15.15
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.55M
Total Cash Per Share (mrq)10.57
Total Debt (mrq)574k
Total Debt/Equity (mrq)2.20%
Current Ratio (mrq)3.86
Book Value Per Share (mrq)11.70

Cash Flow Statement

Operating Cash Flow (ttm)-24.1M
Levered Free Cash Flow (ttm)-14.6M